<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00349024</url>
  </required_header>
  <id_info>
    <org_study_id>CDR0000481526</org_study_id>
    <secondary_id>CCLG-SC-2005-07</secondary_id>
    <secondary_id>EU-20621</secondary_id>
    <nct_id>NCT00349024</nct_id>
  </id_info>
  <brief_title>Polyvinylpyrrolidone-Sodium Hyaluronate Gel in Reducing Pain From Oral Mucositis in Young Patients With Cancer</brief_title>
  <official_title>Efficacy of Gelclairâ„¢ in Reducing the Pain of Oral Mucositis in Children and Young People With Cancer (SC 2005 07)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Cancer and Leukaemia Group</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Polyvinylpyrrolidone-sodium hyaluronate gel may lessen the pain of oral mucositis,
      or mouth sores, in patients undergoing treatment for cancer.

      PURPOSE: This clinical trial is studying how well polyvinylpyrrolidone-sodium hyaluronate gel
      works in reducing pain from oral mucositis in young patients with cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

        -  Examine the feasibility and acceptability of polyvinylpyrrolidone-sodium hyaluronate gel
           in pediatric patients experiencing oral pain from mucositis after cancer therapy.

      OUTLINE: This is a prospective, uncontrolled, open-label, pilot, multicenter study.

      Beginning before hospital discharge or day 3 after chemotherapy, patients use oral
      polyvinylpyrrolidone-sodium hyaluronate gel mouth rinse for at least 1 minute, 3 times per
      day or as needed. Treatment continues for 48 hours. Patients with persistent oral pain may
      continue treatment with polyvinylpyrrolidone-sodium hyaluronate gel beyond 48 hours.

      Oral pain and acceptability (i.e., taste) of polyvinylpyrrolidone-sodium hyaluronate gel are
      assessed periodically using self-reported rating scales.

      PROJECTED ACCRUAL: A total of 50 patients will be accrued for this study.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>July 2005</start_date>
  <primary_completion_date type="Anticipated">December 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Timing and intensity of oral pain</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Duration of action of polyvinylpyrrolidone-sodium hyaluronate gel</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability, effectiveness, and adherence to regimens including polyvinylpyrrolidone-sodium hyaluronate gel</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptoms, other than pain, considered important to the pediatric population</measure>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Brain and Central Nervous System Tumors</condition>
  <condition>Chordoma</condition>
  <condition>Kidney Cancer</condition>
  <condition>Leukemia</condition>
  <condition>Lymphoma</condition>
  <condition>Mucositis</condition>
  <condition>Neuroblastoma</condition>
  <condition>Pain</condition>
  <condition>Sarcoma</condition>
  <condition>Unspecified Childhood Solid Tumor, Protocol Specific</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>polyvinylpyrrolidone-sodium hyaluronate gel</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Diagnosis of cancer, including, but not limited to, the following:

               -  Acute lymphoblastic leukemia

               -  Acute myeloid leukemia

               -  Brain tumor

               -  Hodgkin's lymphoma

               -  Non-Hodgkin's lymphoma

               -  Sarcoma

               -  Wilms' tumor

               -  Neuroblastoma

          -  Meets 1 of the following criteria:

               -  Admitted to an in-patient unit after undergoing chemotherapy that is anticipated
                  to cause oral mucositis

               -  Admitted to an in-patient unit after undergoing myeloablative therapy followed by
                  peripheral blood stem cell or bone marrow transplantation

          -  Is experiencing oral pain due to mucositis

        PATIENT CHARACTERISTICS:

          -  No known hypersensitivity to polyvinylpyrrolidone-sodium hyaluronate gel

        PRIOR CONCURRENT THERAPY:

          -  See Disease Characteristics

          -  Concurrent analgesics allowed
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>19 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faith Gibson, MD</last_name>
    <affiliation>Great Ormond Street Hospital for Children NHS Foundation Trust</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tim O.B. Eden, MB, BS, FRCPE, FRCP, FRCPCH, F</last_name>
    <affiliation>The Christie NHS Foundation Trust</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Our Lady's Hospital for Sick Children Crumlin</name>
      <address>
        <city>Dublin</city>
        <zip>12</zip>
        <country>Ireland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Birmingham Children's Hospital</name>
      <address>
        <city>Birmingham</city>
        <state>England</state>
        <zip>B4 6NH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Child Health at University of Bristol</name>
      <address>
        <city>Bristol</city>
        <state>England</state>
        <zip>BS2 8AE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Addenbrooke's Hospital</name>
      <address>
        <city>Cambridge</city>
        <state>England</state>
        <zip>CB2 2QQ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leeds Cancer Centre at St. James's University Hospital</name>
      <address>
        <city>Leeds</city>
        <state>England</state>
        <zip>LS9 7TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Leicester Royal Infirmary</name>
      <address>
        <city>Leicester</city>
        <state>England</state>
        <zip>LE1 5WW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Liverpool Children's Hospital, Alder Hey</name>
      <address>
        <city>Liverpool</city>
        <state>England</state>
        <zip>L12 2AP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Middlesex Hospital</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>W1T 3AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Great Ormond Street Hospital for Children</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>WC1N 3JH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Manchester Children's Hospital</name>
      <address>
        <city>Manchester</city>
        <state>England</state>
        <zip>M27 4HA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sir James Spence Institute of Child Health at Royal Victoria Infirmary</name>
      <address>
        <city>Newcastle-Upon-Tyne</city>
        <state>England</state>
        <zip>NE1 4LP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen's Medical Centre</name>
      <address>
        <city>Nottingham</city>
        <state>England</state>
        <zip>NG7 2UH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oxford Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <state>England</state>
        <zip>0X3 9DU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital - Sheffield</name>
      <address>
        <city>Sheffield</city>
        <state>England</state>
        <zip>S10 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <state>England</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Marsden - Surrey</name>
      <address>
        <city>Sutton</city>
        <state>England</state>
        <zip>SM2 5PT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Belfast Hospital for Sick Children</name>
      <address>
        <city>Belfast</city>
        <state>Northern Ireland</state>
        <zip>BT12 6BE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Aberdeen Children's Hospital</name>
      <address>
        <city>Aberdeen</city>
        <state>Scotland</state>
        <zip>AB25 2ZG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hospital for Sick Children</name>
      <address>
        <city>Edinburgh</city>
        <state>Scotland</state>
        <zip>EH9 1LF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Royal Hospital for Sick Children</name>
      <address>
        <city>Glasgow</city>
        <state>Scotland</state>
        <zip>G3 8SJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Childrens Hospital for Wales</name>
      <address>
        <city>Cardiff</city>
        <state>Wales</state>
        <zip>CF14 4XW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Ireland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 5, 2006</study_first_submitted>
  <study_first_submitted_qc>July 5, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2006</study_first_posted>
  <last_update_submitted>September 19, 2013</last_update_submitted>
  <last_update_submitted_qc>September 19, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 20, 2013</last_update_posted>
  <keyword>unspecified childhood solid tumor, protocol specific</keyword>
  <keyword>pain</keyword>
  <keyword>childhood acute lymphoblastic leukemia</keyword>
  <keyword>childhood Hodgkin lymphoma</keyword>
  <keyword>chondrosarcoma</keyword>
  <keyword>osteosarcoma</keyword>
  <keyword>childhood soft tissue sarcoma</keyword>
  <keyword>Wilms tumor and other childhood kidney tumors</keyword>
  <keyword>neuroblastoma</keyword>
  <keyword>childhood acute myeloid leukemia/other myeloid malignancies</keyword>
  <keyword>childhood large cell lymphoma</keyword>
  <keyword>childhood lymphoblastic lymphoma</keyword>
  <keyword>childhood small noncleaved cell lymphoma</keyword>
  <keyword>childhood rhabdomyosarcoma</keyword>
  <keyword>childhood brain stem glioma</keyword>
  <keyword>childhood central nervous system germ cell tumor</keyword>
  <keyword>childhood cerebellar astrocytoma</keyword>
  <keyword>childhood cerebral astrocytoma/malignant glioma</keyword>
  <keyword>childhood choroid plexus tumor</keyword>
  <keyword>childhood craniopharyngioma</keyword>
  <keyword>childhood ependymoma</keyword>
  <keyword>childhood medulloblastoma</keyword>
  <keyword>childhood meningioma</keyword>
  <keyword>childhood oligodendroglioma</keyword>
  <keyword>childhood atypical teratoid/rhabdoid tumor</keyword>
  <keyword>childhood spinal cord neoplasm</keyword>
  <keyword>childhood supratentorial primitive neuroectodermal tumor</keyword>
  <keyword>childhood visual pathway and hypothalamic glioma</keyword>
  <keyword>chordoma</keyword>
  <keyword>mucositis</keyword>
  <keyword>Ewing sarcoma/peripheral primitive neuroectodermal tumor (PNET)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lymphoma</mesh_term>
    <mesh_term>Leukemia</mesh_term>
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Sarcoma</mesh_term>
    <mesh_term>Neuroblastoma</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Renal Cell</mesh_term>
    <mesh_term>Mucositis</mesh_term>
    <mesh_term>Nervous System Neoplasms</mesh_term>
    <mesh_term>Central Nervous System Neoplasms</mesh_term>
    <mesh_term>Stomatitis</mesh_term>
    <mesh_term>Chordoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Povidone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

